GlassScriptPhysician profile
John P Harris
NPI 1437234903
$1,307.60
in general payments reported to CMS, 2019-2025
13 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.28 · 2023: $210 · 2024: $655 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $384.12 | 2024 | Daxxify |
| Abbvie INC. | $315.08 | 2023-2025 | |
| Novo Nordisk INC | $146.33 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $139.71 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $127.73 | 2023-2024 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $39.50 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $29.93 | 2019 | |
| Corcept Therapeutics | $28.25 | 2025 | Korlym |
| Amgen INC. | $26.47 | 2019-2025 | Evenity |
| Ani Pharmaceuticals, INC. | $22.39 | 2025 | Purified Cortrophin Gel |
| Exact Sciences Corporation | $19.79 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.00 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.